He has also worked as Associate Researcher of UMR CNRS 8612 'Physico-chimie, Pharmacotechnie et Biopharmacie' at the Universite Paris-Sud, France. His research group is actively involved in the development of colloidal drug delivery systems against severe diseases (cancer, autoimmune diseases, infectious diseases, etc.). His area of specialization includes a focus on the formulation of advanced drug nanocarriers on the basis of passive and active targeting strategies. More recently, he has commenced work on engineering strategies for the preparation of theragnostic nanoparticles.